Syncom Formulations India Q3 Results

  • BSE: 524470
  • NSE: SYNCOMF
  • ISIN: INE312C01025
  • Sector: Biotechnology & Drugs
BSE
19.580.07 (0.36%)
Volume4.85 L
Updated: Mon 25 Nov, 2024 | 15:55:07
NSE
19.580.08 (0.41%)
Volume1.97 M
Updated: Mon 25 Nov, 2024 | 15:40:23
Today: 19.51
20.31
52-Wk: 9.80
27.94

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Syncom Formulations India Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 65.1463.84-%57.38-%
    Selling/ General/ Admin Expenses Total 9.749.00-%7.26-%
    Depreciation/ Amortization 1.450.88-%1.20-%
    Other Operating Expenses Total 8.529.33-%9.45-%
    Total Operating Expense 59.2558.31-%52.68-%
    Operating Income 5.895.53-%4.70-%
    Net Income Before Taxes 9.368.45-%5.97-%
    Net Income 7.006.51-%4.14-%
    Diluted Normalized EPS 0.090.08-%0.06-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts